BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4141984)

  • 1. Effect of neuraminidase-treated and mitomycin C-treated polyoma tumour cells on the established tumour growth in CBA mice. I. An attempt at evaluation of polyoma tumour destruction using the distribution of lissamine green method.
    Porwit-Bóbr Z; Slowik M; Tomecki J
    Folia Histochem Cytochem (Krakow); 1974; 12(3-4):315-20. PubMed ID: 4141984
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative protection by polyoma virus and xenogenic polyoma-induced tumour cells against tumour allograft.
    Favre R
    Pathol Biol (Paris); 1974 Jan; 22(1):13-6. PubMed ID: 4360752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Inhitrypsin preparation on transplantability of polyoma tumor cells in CBA mice].
    Payerhin F; Porwit-Bóbr Z; Pawełek J; Krzek J
    Med Dosw Mikrobiol; 1979; 31(3):193-8. PubMed ID: 229362
    [No Abstract]   [Full Text] [Related]  

  • 6. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours.
    Franzén AV; Tegerstedt K; Holländerova D; Forstová J; Ramqvist T; Dalianis T
    In Vivo; 2005; 19(2):323-6. PubMed ID: 15796193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mitomycin-C on McCall rat colon adenocarcinoma.
    Sugiura K; Stock CC
    Gan; 1978 Oct; 69(5):715-7. PubMed ID: 556349
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron microscopic study of polyoma-induced salivary gland tumors, with special reference to cell-virus interactions.
    Imamura M
    J Natl Cancer Inst; 1968 Dec; 41(6):1265-83. PubMed ID: 4178160
    [No Abstract]   [Full Text] [Related]  

  • 11. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of glutaraldehyde fixation on the immunogenicity of allogeneic lymphoid and tumour cells.
    Milton JD
    Immunology; 1980 Nov; 41(3):715-21. PubMed ID: 6780448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of various tumor-specific antigens in polyoma virus-induced tumors.
    Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB
    Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472
    [No Abstract]   [Full Text] [Related]  

  • 15. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
    Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
    Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment on the carcinogenic potential of hybridoma cell DNA: implications for residual contaminating cellular DNA in biological products.
    Dortant PM; Claassen IJ; van Kreyl CF; van Steenis G; Wester PW
    Biologicals; 1997 Dec; 25(4):381-90. PubMed ID: 9467034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of cyclophosphamide-treated leukaemia cells.
    Kawalec M; Jakóbisiak M; Skórski T; Kawiak J
    Folia Biol (Praha); 1982; 28(5):334-43. PubMed ID: 6816636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of BCG and neuraminidase in experimental tumor immunotherapy.
    Simmons RL; Rios A
    Surg Forum; 1971; 22():99-101. PubMed ID: 4941334
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological control of polyoma virus oncogenesis in mice.
    Gaugas JM; Allison AC; Chesterman FC; Rees RJ; Hirsch MS
    Br J Cancer; 1973 Jan; 27(1):10-7. PubMed ID: 4346752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immunoprophylaxis in experimental tumour-host systems.
    Prager MD; Gordon WC
    Can Med Assoc J; 1980 Apr; 122(7):780-4. PubMed ID: 7363246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.